Sign in

NCT07375407Completed

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

The Effect of Aerobic Exercise and Physiological Ischemic Training on VEGF, Interleukin-6, Interleukin-10, Cardiorespiratory Fitness, Muscle Strength, and Quality of Life in Patients With Hypertension

Source: ClinicalTrials.gov · Last updated 2 Feb 2026

Brief summary (registry, in English)

This study aims to compare the effects of aerobic exercise (AE) and physiological ischemic training (PIT) on inflammatory and angiogenesis biomarkers (VEGF, IL-6, IL-10), cardiorespiratory fitness, muscle strength, and quality of life in patients with grade 2 primary hypertension (HT2). This randomized controlled trial will involve 60 HT2 patients from Pratama and Utama Medika Antapani Clinic, who will be assigned to either AE or PIT groups. The intervention will last 6 weeks, and outcomes measured will include biomarker levels, VO2max, 6-minute walk distance (6-MWD), maximum voluntary contraction (MVC), and SF-36 questionnaire scores.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
21 Jan 2026
Start date
5 Aug 2023
Primary completion date
5 Dec 2023
Lead sponsor
Universitas Padjadjaran
NCT number
NCT07375407

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 5 Aug 2023 to the primary completion date, 5 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with unstable angina
  • Malignant arrhythmias and high atrioventricular block
  • Uncontrolled hypertension
  • Severe valvular heart disease
  • Chronic obstructive pulmonary disease
  • Cor pulmonale and pulmonary vascular disease
  • Cognitive impairment
  • Subjects experiencing infection or inflammation
  • Subjects with neuromuscular disorders that may affect the study results
  • Subjects with musculoskeletal disorders that may affect the study results
  • Complications or comorbidities such as cerebrovascular disease, CAD, atheroma plaques on imaging, heart failure, PAD, and atrial fibrillation.

Other

  • Unstable hemodynamics
  • Acute pericarditis
  • Thrombophlebitis
  • Intermittent claudication
  • Uncooperative subjects

Who the study is looking for

  • Primary hypertension patients aged 18-65 years
  • Diagnosed with grade 2 primary hypertension
  • Willing to participate in the study

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hasan sadikin general hospital
Coordinator of this site? Confirm its status
BandungIndonesiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.